Mass spec studio: business intelligence software for the international laboratory industry (a Phase IIb project)

许多慢性人类疾病仍然得不到很好的治疗。癌症、关节炎、胃肠道紊乱、肾脏疾病等许多疾病缺乏有效的治疗方法。现代医学的目标是开发治疗这些疾病的药物，提高社会的健康水平。这项工作涉及对疾病性质、药物产品发现和开发以及药物监测的基础研究。所有这些活动涉及多个行业，严重依赖于分子分析的科学工具，如质谱仪。这些工具用于发现药物，缩短药物开发的路径，确保产品安全，并确定药物是否对人群有效。质谱仪，像许多现代分析工具一样，产生复杂的数据流，难以解释。当前的项目将启动一个名为Mass Spec Studio的强大开发框架，用于创建数据分析软件产品。这个专有框架是一个应用程序开发生成器，支持质谱，可以扩展到其他技术。该项目将推出旗舰产品HXauto，用于测量生物制剂的安全性和稳定性，这是一种重要的新型药物治疗。HXauto的成功商业化将验证我们的商业计划，并与一家主要的国际生命科学公司合作，成立一家新的加拿大软件设计公司。

Many chronic human conditions remain poorly treated. Diseases like cancer, arthritis, gastrointestinal disorders, kidney disease and many others lack effective therapies. It is the goal of modern medicine to develop drugs for these diseases and improve the health-span of society. The effort involves fundamental research into the nature of disease, drug product discovery and development, and drug monitoring. All these activities stretch over multiple industries and rely heavily upon scientific tools of molecular analysis, like the mass spectrometer. These tools are used to discover drugs, shorten the path to their development, ensure product safety and determine if the drugs are working in the population. Mass spectrometers, like many modern tools of analysis, generate complex data streams that are difficult to interpret. The current project will launch a powerful development framework called the Mass Spec Studio to create software products for data analytics. This proprietary framework is an app development generator that supports mass spectrometry and can be expanded to other techniques. The project will deliver its flagship product (HXauto) for measuring the safety and stability of biologics, an important new class of drug therapy. Successful commercialization of HXauto will validate our business plans and lead to a new Canadian software design firm in partnership with a major international life sciences company.